Cargando…
Long-term outcomes of the Nexgen(©) posterior stabilized knee: minimum 15 year follow—safe and effective
PURPOSE: Studying long-term survivorship and functional outcomes for specific prostheses is critical for elucidating areas in need of design improvement. This study reports the long-term of the NexGen Posterior Stabilized (PS) Total Knee implant (TKA) (Zimmer Biomet, Warsaw IN) Performed by a single...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Paris
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10009351/ https://www.ncbi.nlm.nih.gov/pubmed/36912950 http://dx.doi.org/10.1007/s00590-023-03514-0 |
_version_ | 1784905965035847680 |
---|---|
author | Cohen, Daniel Greenberg, Arieh Maliarov, Anton Seligman, David Backstein, David |
author_facet | Cohen, Daniel Greenberg, Arieh Maliarov, Anton Seligman, David Backstein, David |
author_sort | Cohen, Daniel |
collection | PubMed |
description | PURPOSE: Studying long-term survivorship and functional outcomes for specific prostheses is critical for elucidating areas in need of design improvement. This study reports the long-term of the NexGen Posterior Stabilized (PS) Total Knee implant (TKA) (Zimmer Biomet, Warsaw IN) Performed by a single surgeon. METHODS: Data from patients treated with the NexGen PS TKA between January 2003 and December 2005 with a minimal follow-up of 15 years was collected from a prospectively collected database. Survivorship rates and Oxford Knee Scores (OKS) were obtained for those patients available for follow-up. RESULTS: Ninety-five patients met the inclusion criteria during the study period. OKS was available for 44 (46%) patients. Ten patients required revision surgery (10.52%). Implant-specific survivorship of all cases that were reviewed was 98%. Survivorship of implants in patients that we were able to reach, or deceased patients was 93%. The average Oxford Knee Score was 39.1 (14–48. SD ± 7.70) with 48 being the maximal score. CONCLUSION: Despite some concerns about durability of this implant, good longevity and function was demonstrated. At a minimum of 15 years follow-up in this cohort. Given these results design features of this system should be considered for future generations of implants. |
format | Online Article Text |
id | pubmed-10009351 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Springer Paris |
record_format | MEDLINE/PubMed |
spelling | pubmed-100093512023-03-13 Long-term outcomes of the Nexgen(©) posterior stabilized knee: minimum 15 year follow—safe and effective Cohen, Daniel Greenberg, Arieh Maliarov, Anton Seligman, David Backstein, David Eur J Orthop Surg Traumatol Original Article PURPOSE: Studying long-term survivorship and functional outcomes for specific prostheses is critical for elucidating areas in need of design improvement. This study reports the long-term of the NexGen Posterior Stabilized (PS) Total Knee implant (TKA) (Zimmer Biomet, Warsaw IN) Performed by a single surgeon. METHODS: Data from patients treated with the NexGen PS TKA between January 2003 and December 2005 with a minimal follow-up of 15 years was collected from a prospectively collected database. Survivorship rates and Oxford Knee Scores (OKS) were obtained for those patients available for follow-up. RESULTS: Ninety-five patients met the inclusion criteria during the study period. OKS was available for 44 (46%) patients. Ten patients required revision surgery (10.52%). Implant-specific survivorship of all cases that were reviewed was 98%. Survivorship of implants in patients that we were able to reach, or deceased patients was 93%. The average Oxford Knee Score was 39.1 (14–48. SD ± 7.70) with 48 being the maximal score. CONCLUSION: Despite some concerns about durability of this implant, good longevity and function was demonstrated. At a minimum of 15 years follow-up in this cohort. Given these results design features of this system should be considered for future generations of implants. Springer Paris 2023-03-13 /pmc/articles/PMC10009351/ /pubmed/36912950 http://dx.doi.org/10.1007/s00590-023-03514-0 Text en © The Author(s), under exclusive licence to Springer-Verlag France SAS, part of Springer Nature 2023, Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
spellingShingle | Original Article Cohen, Daniel Greenberg, Arieh Maliarov, Anton Seligman, David Backstein, David Long-term outcomes of the Nexgen(©) posterior stabilized knee: minimum 15 year follow—safe and effective |
title | Long-term outcomes of the Nexgen(©) posterior stabilized knee: minimum 15 year follow—safe and effective |
title_full | Long-term outcomes of the Nexgen(©) posterior stabilized knee: minimum 15 year follow—safe and effective |
title_fullStr | Long-term outcomes of the Nexgen(©) posterior stabilized knee: minimum 15 year follow—safe and effective |
title_full_unstemmed | Long-term outcomes of the Nexgen(©) posterior stabilized knee: minimum 15 year follow—safe and effective |
title_short | Long-term outcomes of the Nexgen(©) posterior stabilized knee: minimum 15 year follow—safe and effective |
title_sort | long-term outcomes of the nexgen(©) posterior stabilized knee: minimum 15 year follow—safe and effective |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10009351/ https://www.ncbi.nlm.nih.gov/pubmed/36912950 http://dx.doi.org/10.1007/s00590-023-03514-0 |
work_keys_str_mv | AT cohendaniel longtermoutcomesofthenexgenposteriorstabilizedkneeminimum15yearfollowsafeandeffective AT greenbergarieh longtermoutcomesofthenexgenposteriorstabilizedkneeminimum15yearfollowsafeandeffective AT maliarovanton longtermoutcomesofthenexgenposteriorstabilizedkneeminimum15yearfollowsafeandeffective AT seligmandavid longtermoutcomesofthenexgenposteriorstabilizedkneeminimum15yearfollowsafeandeffective AT backsteindavid longtermoutcomesofthenexgenposteriorstabilizedkneeminimum15yearfollowsafeandeffective |